Welcome to the International Society for Vaccines

Skip to main content

Megan Polidano


Megan joined Vaxxas Pty Ltd as the Head of Clinical Research and Regulatory Affairs in March 2021. She is responsible for the clinical development of Vaxxas product portfolio and for overseeing the regulatory affairs function with the company. Megan has over 20 years of experience working in this area and is passionate about the translation of novel research into commercialized therapeutic products that can make a difference to people’s lives.

Megan started her regulatory affairs career at CSL, working on novel vaccine technologies and was responsible for managing the registration of seasonal Influenza vaccine across Europe. At CSL, she also managed their in-licensed vaccine portfolio. Throughout her career she has been responsible for the development of regulatory and clinical strategy, maintenance of product registration and for registering new medicines and medical devices across a broad range of therapeutics areas. Megan has held senior regulatory and clinical roles in both the pharmaceutical and medical device companies including PolyNovo, Pfizer and LEO Pharma and has also spent time working as a consultant. Prior to joining Vaxxas, Megan was a Senior Project Manager at QBiotics developing a novel topical wound healing product.

Megan obtained an undergraduate degree (with Honours) in Applied Biology/Biotechnology from the Royal Melbourne Institute of Technology and a Ph.D degree from the Department of Biochemistry and Molecular Biology at the University of Melbourne. She also completed post-doctoral research at Cognetix Inc (Salt Lake City).

ISV Fellow of the Month
United States